References
- Cho JJ and Kim Y. 2002. Sharks : A potential source of antiangiogenic featos and tumor treatments. Marine Biotechnology 4, 521-525. https://doi.org/10.1007/s10126-002-0064-3
- Folkman J and Cotran R. 1976. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 16, 207-248.
- Gorham PR and Carmichael WW. 1979. Phycotoxins from blue-green algae. Pure Appl Chem 52, 165-174.
- Haefner B. 2003. Drugs from the deep: marine natural products as drug candidates. Drug discovery Today 8, 536-544. https://doi.org/10.1016/S1359-6446(03)02713-2
- Jeong SJ. 2011. Antiangiogenic phytochemicals and medicinal herbs. Physiotherapy Research 25, 1-10.
- Mignatti P and Rifkin DB. 1996. Plaminogen activators and matrix metalloproteinase in angiogenesis. Enzyme Protein 49, 117-137. https://doi.org/10.1159/000468621
- Min DK. 2004. Mollusks in Korea. Hangeul Graphics, Busan, Korea, 387.
- Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Method 65, 55-63. https://doi.org/10.1016/0022-1759(83)90303-4
- Schantz EJ, McFarren EF, Schafer ML and Lewis KH. 1958. Purified shellfish poisons bioassay standardization. AOAC 41, 160-168.
- Scheuer PJ. 1970. Toxins from fish and other organisms. Advanced in Food Research 18, 141-161. https://doi.org/10.1016/S0065-2628(08)60369-9
- Timar J, Domae B, Fazekas K, Janovics A and Paku S. 2001. Angiogenesis-dependent diseases and angiogenesis therapy. Pathol Oncol Res 7, 85-94. https://doi.org/10.1007/BF03032573
- Veikkola T and Alitalo K. 1999. VEGFs, receptors and angiogenesis. Semin Cancer Biol 9, 211-220. https://doi.org/10.1006/scbi.1998.0091
- Yi EY, Park SY, Choi JS, Lim CW, Kim YK, Park HY and Kim YJ. 2008. A natural marine compound extracted from the Ark shell, Scapharca subcrenata, inhibits in vivo and in vitro angiogenesis. Cancer Prevention Res 13, 47-53.
- Yoo JS. 1976. Korean Shells in Colour. Iljisa, Seoul, Korea, 196.